Private vs Public: Privacy in Trials
There was quite a ruckus in the cancer drug development community when Memorial Sloan Kettering Cancer…
Biotechnology & Madison High Schools
At the Biotech in WI Meetup this week, we learned about the Biotechnology elective…
R&D Scientists: Welcome to Your Contract
This tweet recently caught my eye. (I'm assuming pharma here is drug related, including…
Walking the Walk: Stories of Drug Development
When I first started writing here in 2011, I thought that the time was…
Partnering Tidbits from Turin
I've escaped the cube farm long enough to share a few thoughts from BIO-Europe…
Personal Risk & Social Media in Pharma/Biotech
Benefit: Something that promotes or enhances well-being Risk: the possibility of suffering harm or…
Weekend Reading List 2/15/14
Inspired by the Biotech Reading List over at BioDueDiligence, I thought I would share…
Is Biotech Venture Capital Dying?
This post was inspired by the Xconomy story Wisconsin 2013 VC Activity Drops, Shifts…
Social Media & Cancer Drugs: Conversation, not Promotion
*This post was originally posted at Xconomy.* (Updated to include Lilly COI in table based…
#JPM14 Mad Libs
Here is a short JP Morgan Themed Mad Libs to keep you entertained between…
Load More